2020-2024 Comprehensive analysis on Heart Stent Market Size | Key Players are: Abbott, Medtronic, Boston, Biosensor, Terumo, MicroPort, HEXACATH, Biotronik, ClearStream

The growing demand for Heart Stent has provided a major boost to the Global Heart Stent Market as more people are shifting their preferences to this growing sector. The market is expected to keep rising at a high CAGR and reach values of high millions by the end of the forecast period of 2020 up to 2024.

Global Heart Stent Market overview:

BIR Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/251009 .

A heart stent is a tiny wire mesh tube. It props open an artery and is left there permanently. When a coronary artery (an artery feeding the heart muscle) is narrowed by a buildup of fatty deposits called plaque, it can reduce blood flow. If blood flow is reduced to the heart muscle, chest pain can result. The Global Heart Stent Market is segmented on the basis of Product Type, Application, End Use Industry and Region.

On the Basis of Product Type segment, the Heart Stent Market is sub segmented into Drug-Eluting Stent, Bare Metal Stent, Bioactive Stent and Radioactive Stent. Based on End Use Industry segment, the Heart Stent Market is sub segmented into Acute Myocardial Infarction, Unstable Angina and Angina Pectoris. The heart stent market is witnessing a new phase of technological developments, with the launch of fully dissolving heart stent.

Some of the Heart Stent Market manufacturers involved in the market are Abbott, Medtronic, Boston Scientific, Biosensor International, Terumo, MicroPort Scientific, Lepu Medical, B.Braun, HEXACATH, Biotronik AG, ClearStream in World; effective mergers are some of the strategies adopted by the Heart Stent Market manufacturers. New product launches and continuous technological innovations are the Heart Stent Market strategies adopted by the major players.

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on "Heart Stent Market Report 2020" @ https://www.businessindustryreports.com/buy-now/251009/single .

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study.

There are several manufacturers of Heart Stents in Europe and North America. In North America, the demand for Heart Stents is primarily driven by the Healthcare sector. Among the countries in Asia Pacific, the demand was substantially high in developing countries such as China and India. These countries have been witnessing rapid increase in its population along with expansion of their overall economies, which has led to increase in disposable income.

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/251009 .

Top Industry News:

Medtronic Onyx ONE Clear Study of One-Month Dual-Antiplatelet Therapy in High Bleeding Risk Stent Patients Beats Performance Goal on 30 March, 2020 -- Medtronic plc today announced positive results of the Onyx ONE Clear Study that evaluated Resolute Onyx DES in high bleeding risk (HBR) patients with one-month dual antiplatelet therapy (DAPT) in the United States and Japan. The study met its primary endpoint of cardiac death or myocardial infarction by beating a performance goal derived from contemporary one-month DAPT trials at one-year post-procedure. Results from the study were shared virtually at the American College of Cardiology together with the World Congress of Cardiology Scientific Sessions (ACC.20/WCC) on March 28, 2020.

"Despite the high-risk population, we observed a low rate of ischemic outcomes after DAPT discontinuation at one month," said Ajay Kirtane, M.D., professor of medicine at Columbia University Irving Medical Center, lead investigator and presenter of the data at ACC.20. "These data, in conjunction with the randomized data from the Onyx ONE Global randomized controlled trial, offer additional clinical evidence of one-month of DAPT for appropriately selected patients treated with the Resolute Onyx DES."

The prospective, multicenter, single-arm study included highly complex HBR patients in the U.S. and Japan who were treated with one-month DAPT (the combination of aspirin and an anti-clotting medication) following PCI with Resolute Onyx and were clear of any adverse events and were DAPT compliant at one month. Patients in the Onyx ONE Clear Study were pooled with similar patients treated with Resolute Onyx from the Onyx ONE Global Study, totaling approximately 1500 patients that were included in the primary endpoint analysis. The Onyx ONE Clear study's primary composite endpoint of cardiac death or myocardial infarction was 7.0%, beating the pre-specified performance goal of 9.7% at one-year post-procedure. The rate of stent thrombosis was low at 0.7% at one year. The performance goal was based on short-DAPT studies.

The Onyx ONE Clear Study was designed to complement the Onyx ONE Global Study, results of which wererecently published in the New England Journal of Medicine. Together, the Onyx ONE Clear Study and the Onyx ONE Global Study make up the robust Medtronic Onyx ONE Month DAPT Program that has enrolled approximately 2,700 patients at up to 130 sites worldwide.

"Onyx ONE Clear demonstrates our commitment to providing the clinical evidence of greatest interest and benefit to the interventional cardiology community," said Dave Moeller, vice president and general manager of the Coronary and Renal Denervation business, which is part of the Cardiac and Vascular Group at Medtronic. "We hope these data will support our submission to the FDA for a one-month DAPT indication for high-bleeding risk patients treated with Resolute Onyx."

Table of Contents:

1 Heart Stent Product Definition
2 Global Heart Stent Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Heart Stent Shipments
2.2 Global Manufacturer Heart Stent Business Revenue
2.3 Global Heart Stent Market Overview
3 Manufacturer Heart Stent Business Introduction
3.1 Abbott Heart Stent Business Introduction
3.1.1 Abbott Heart Stent Shipments, Price, Revenue and Gross profit 2014-2019
3.1.2 Abbott Heart Stent Business Distribution by Region
3.1.3 Abbott Interview Record
3.1.4 Abbott Heart Stent Business Profile
3.1.5 Abbott Heart Stent Product Specification
3.2 Medtronic Heart Stent Business Introduction
3.2.1 Medtronic Heart Stent Shipments, Price, Revenue and Gross profit 2014-2019
3.2.2 Medtronic Heart Stent Business Distribution by Region
3.2.3 Interview Record
3.2.4 Medtronic Heart Stent Business Overview
3.2.5 Medtronic Heart Stent Product Specification
3.3 Boston Scientific Heart Stent Business Introduction
3.3.1 Boston Scientific Heart Stent Shipments, Price, Revenue and Gross profit 2014-2019
3.3.2 Boston Scientific Heart Stent Business Distribution by Region
3.3.3 Interview Record
3.3.4 Boston Scientific Heart Stent Business Overview
3.3.5 Boston Scientific Heart Stent Product Specification
3.4 Biosensor International Heart Stent Business Introduction
3.5 Terumo Heart Stent Business Introduction
3.6 MicroPort Scientific Heart Stent Business Introduction
................... Request free sample to get a complete Table of Content

About us

BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined - we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune - India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.